What Is CJC-1295? How It Works and Clinic Uses
CJC-1295 is a synthetic peptide that stimulates growth hormone release. Learn what it is, how it works, and how licensed clinics use it.
What Is CJC-1295?
CJC-1295 is a synthetic peptide — a short chain of amino acids — engineered to mimic and extend the action of growth hormone-releasing hormone (GHRH). GHRH is the body's natural signal to the pituitary gland to produce and secrete human growth hormone (HGH). CJC-1295 was originally developed to treat growth hormone deficiencies, but today it's primarily offered through compounding pharmacies and licensed peptide-therapy clinics as part of broader hormone optimization protocols.
It's important to know upfront: CJC-1295 is not an FDA-approved drug for general use. Most clinical preparations are compounded, meaning they're mixed by licensed compounding pharmacies rather than manufactured by an FDA-approved pharmaceutical facility. This distinction matters when evaluating any clinic's offering. Always consult a licensed physician before considering this or any peptide therapy.
The Science Behind It
To understand CJC-1295, you need a basic picture of the growth hormone axis. The hypothalamus releases GHRH, which travels to the pituitary gland and triggers GH secretion. GH then stimulates the liver to produce insulin-like growth factor 1 (IGF-1), which drives the downstream effects most people associate with GH — tissue repair, fat metabolism, muscle protein synthesis, and more.
Natural GHRH breaks down quickly in the bloodstream — its half-life is only a few minutes. CJC-1295 was designed to solve that problem. The version most commonly used in clinical settings is CJC-1295 with DAC (Drug Affinity Complex), a modification that allows the peptide to bind to albumin, a protein naturally present in the blood. That binding dramatically extends its half-life to approximately 6–8 days, compared to minutes for native GHRH.
The result is a more sustained elevation of GH pulse frequency and amplitude rather than a single sharp spike. This mirrors the body's own pulsatile GH release pattern more closely than exogenous HGH injections do — at least in theory. Research published through NIH/PubMed has investigated CJC-1295's pharmacokinetics and its ability to produce dose-dependent increases in GH and IGF-1 levels.
CJC-1295 vs. CJC-1295 Without DAC (MOD GRF 1-29)
You'll frequently see two versions listed at clinics:
- CJC-1295 with DAC — longer-acting, typically dosed once or twice weekly
- CJC-1295 without DAC (also called MOD GRF 1-29) — shorter half-life, usually dosed more frequently alongside a separate GHRP (growth hormone releasing peptide)
The "without DAC" version is often paired with peptides like ipamorelin to create a synergistic effect — stimulating GH release through two complementary pathways at the same time. Clinics may offer either version depending on the patient's goals and the prescribing physician's protocol.
How Clinics Use CJC-1295
Licensed peptide clinics typically incorporate CJC-1295 into protocols targeting several overlapping goals:
Hormone Optimization As GH and IGF-1 levels naturally decline with age, some patients and clinicians explore GHRH analogs as a way to support the body's own hormone production rather than introducing exogenous HGH directly. Clinics offering hormone optimization panels often measure baseline IGF-1 before and during any peptide protocol.
Body Composition GH plays a well-documented role in lipolysis (fat breakdown) and lean muscle support. Clinics frequently position CJC-1295 within protocols aimed at improving body composition, particularly in patients who are also addressing metabolic health. It is sometimes stacked with ipamorelin for this purpose.
Recovery and Tissue Repair GH is central to cellular repair processes. Some sports medicine and wellness clinics include CJC-1295 in recovery-focused protocols for patients dealing with slower healing, though clinical evidence specific to injury recovery remains limited compared to more studied interventions.
Anti-Aging and Wellness Sleep quality, skin integrity, and energy levels are all loosely connected to GH axis function. Some longevity-focused clinics include CJC-1295 as part of broader anti-aging panels, though claims in this space should be interpreted cautiously until more robust clinical data exists.
What Clinics Typically Offer
A standard clinical offering usually includes:
- Initial lab work — baseline IGF-1, metabolic panel, and a physician consultation
- Compounded injectable peptide — most preparations are subcutaneous injections, though protocols vary
- Ongoing monitoring — follow-up labs to track IGF-1 response and assess tolerability
- Combination protocols — CJC-1295 is rarely offered in isolation; pairing with ipamorelin is especially common
Reported side effects noted in research and clinical settings include water retention, headache, flushing, and injection-site reactions. Because CJC-1295 stimulates — rather than replaces — the pituitary's own GH output, some clinicians consider it a more physiologically conservative approach than direct HGH administration. That said, stimulating GH still carries risks, and anyone with active malignancy, diabetic retinopathy, or certain other conditions should avoid GH-stimulating therapies entirely.
Key Things to Ask a Clinic
Before starting any CJC-1295 protocol, ask your provider:
- Is this compounded or pharmaceutical-grade, and from which pharmacy?
- Will I have baseline and follow-up IGF-1 testing?
- Is a licensed physician reviewing my labs and supervising my protocol?
- What is the clinic's protocol if I experience side effects?
The quality of compounded peptides can vary between pharmacies. Reputable clinics work with FDA-registered 503B outsourcing facilities or PCAB-accredited compounding pharmacies. It's a reasonable question to ask before committing.
Bottom Line
CJC-1295 is a GHRH analog designed to stimulate the body's own growth hormone production in a sustained, pulsatile manner. It's offered by many licensed peptide and hormone optimization clinics, often alongside ipamorelin or other peptides, for goals ranging from body composition to recovery and longevity. The research base is growing but still maturing — and because it's a compounded, non-FDA-approved preparation, working with a qualified, supervising physician isn't optional. It's essential.
This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide or hormone therapy.